Related Experiment Video
Updated: Jun 3, 2025

Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
Epigenetic Mechanisms in Osteoporosis: Exploring the Power of m6A RNA Modification
Shuo Tian1,2, Yagang Song1,2, Lin Guo3
1Academy of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, China.
Abstract:
Osteoporosis, recognised as a metabolic disorder, has emerged as a significant burden on global health. Although available treatments have made considerable advancements, they remain inadequately addressed. In recent years, the role of epigenetic mechanisms in skeletal disorders has garnered substantial attention, particularly concerning m6A RNA modification. m6A is the most prevalent dynamic and reversible modification in eukaryotes, mediating various metabolic processes of mRNAs, including splicing, structural conversion, translation, translocation and degradation and serves as a crucial component of epigenetic modification. Research has increasingly validated that m6A plays a vital role in the proliferation, differentiation, migration, invasion,and repair of bone marrow mesenchymal stem cells (BMSCs), osteoblasts and osteoclasts, all of which impact the whole process of osteoporosis pathogenesis. Continuous efforts have been made to target m6A regulators and natural products derived from traditional medicine, which exhibit multiple biological activities such as anti-inflammatory and anticancer effects, have emerged as a valuable resources for m6A drug discovery. This paper elaborates on m6A methylation and its regulatory role in osteoporosis, emphasising its implications for diagnosis and treatment, thereby providing theoretical references.
Insights
N-methyl-26-adenosine (m6A) RNA modification is crucial in osteoporosis. Targeting m6A regulators and natural products offers new therapeutic avenues for this metabolic bone disorder.
Area of Science:
- Biochemistry
- Molecular Biology
- Epigenetics
Background:
- Osteoporosis is a global health burden with unmet treatment needs.
- Epigenetic mechanisms, especially m6A RNA modification, are increasingly recognized in skeletal disorders.
- m6A is the most abundant RNA modification, regulating mRNA metabolism and gene expression.
Purpose of the Study:
- To elaborate on the role of m6A methylation in osteoporosis pathogenesis.
- To highlight the implications of m6A regulators in bone cell biology.
- To explore natural products as potential therapeutic resources targeting m6A.
Main Methods:
- Review of current literature on m6A RNA modification and osteoporosis.
- Analysis of m6A's role in bone marrow mesenchymal stem cells, osteoblasts, and osteoclasts.
- Investigation of natural products with anti-inflammatory and anticancer properties for m6A drug discovery.
Main Results:
- m6A modification significantly impacts bone cell proliferation, differentiation, migration, invasion, and repair.
- Dysregulation of m6A regulators is implicated in osteoporosis development.
- Natural products show promise as sources for developing novel m6A-targeting osteoporosis therapies.
Conclusions:
- m6A RNA modification is a critical epigenetic regulator in osteoporosis.
- Targeting m6A pathways presents a promising strategy for osteoporosis diagnosis and treatment.
- Further research into m6A regulators and natural products can advance osteoporosis therapeutics.
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Regulation of Expression at Multiple Steps
Epigenetic Regulation
X-chromosome...
Nuclear Export of mRNA
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

